Leinco Technologies Mouse Anti-Mouse PD-1 Antibody (Clone: 384-35) for cancer immunotherapy research

Click2Contact

In the fast-evolving field of cancer research, selecting the right tools is crucial for advancing discovery and achieving reliable results. When it comes to blocking PD-1/PD-L1 interactions, the Mouse Anti-Mouse PD-1 Antibody (Clone: 384-35), developed by Leinco Technologies, offers high performance across critical research areas.

The efficiency of an antibody’s blocking capability can make or break the outcome of research. Leinco says its product surpasses the widely used RMP1-14 by blocking PD-L1 binding to PD-1 with 25% greater efficiency. This increase in blocking power should translate to more accurate results, helping researchers draw more definitive conclusions from their experiments.

One of the biggest challenges in extended in vivo studies is maintaining consistent results over time. The antibody has been designed to retain its effectiveness throughout the course of long-term experiments, giving researchers trust in their data. This is particularly beneficial for those conducting extended studies where reproducibility is essential.

Survival outcomes are a key indicator of therapeutic efficacy, especially in preclinical studies. Studies have shown that the administration of the antibody leads to survival rates extending beyond 100 days in mouse models, which is longer than what is typically observed with RMP1-14. This is advantageous for researchers aiming to demonstrate the long-term benefits of their interventions.

When fighting aggressive tumour growth, every reduction in volume counts. The antibody is said to deliver a 2.5-fold reduction in tumour size compared to alternatives, offering researchers more control in tumour suppression studies. It could thus be a game-changing tool for those working at the frontier of cancer immunotherapy research.

For researchers focused on developing new cancer immunotherapies, conducting in vivo mouse studies or simply looking to add to their research toolkit, the Mouse Anti-Mouse PD-1 Antibody (Clone: 384-35) is a high-performance antibody that can elevate their work and advance their research, thanks to its benefits in blocking efficiency, survival extension and tumour control.